Literature DB >> 7533093

Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants.

P Bufler1, G Stiegler, M Schuchmann, S Hess, C Krüger, F Stelter, C Eckerskorn, C Schütt, H Engelmann.   

Abstract

The receptor for lipopolysaccharide LPS (CD14) exists in a membrane-associated (mCD14) and a soluble form (sCD14). Previous studies indicate that monocytes produce sCD14 by limited proteolysis of the membrane-bound receptor. In this study we demonstrate that human monocytes also produce sCD14 by a protease-independent mechanism. To investigate the molecular nature of this second pathway we studied sCD14 formation in the monocytic cell line Mono Mac 6 (MM6) and in CD14 transfectants. Both MM6 and the CD14 transfectants constitutively produce sCD14 by a protease-independent mechanism. Structural analysis of sCD14 produced by the CD14 transfectants reconfirmed the presence of the COOH terminus predicted from the cDNA. Since glycosylphosphatidylinositol anchor attachment is associated with the removal of a hydrophobic C-terminal signal peptide, our finding demonstrates that the transfectants secrete sCD14 which escaped this posttranslational modification. Identical results obtained for sCD14 derived from peritoneal dialysis fluid of a patient with kidney dysfunction show the in vivo relevance of this pathway for sCD14 production.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7533093     DOI: 10.1002/eji.1830250244

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  27 in total

Review 1.  The biology of endotoxin.

Authors:  H Heine; E T Rietschel; A J Ulmer
Journal:  Mol Biotechnol       Date:  2001-11       Impact factor: 2.695

2.  Myelopeptide 6, a novel endogenous bone marrow-derived differentiation factor.

Authors:  E A Kirilina; A A Mikhailova; M A Efremov; R V Petrov
Journal:  Dokl Biol Sci       Date:  2008 Jul-Aug

3.  Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site.

Authors:  Lan Lin; Elizabeta Nemeth; Julia B Goodnough; Dharma R Thapa; Victoria Gabayan; Tomas Ganz
Journal:  Blood Cells Mol Dis       Date:  2007-09-14       Impact factor: 3.039

4.  CD14 contributes to warm hepatic ischemia-reperfusion injury in mice.

Authors:  Changchun Cai; Xiaolian Shi; Sebastian Korff; Jinxiang Zhang; Patricia A Loughran; Xiangcai Ruan; Yong Zhang; Li Liu; Timothy R Billiar
Journal:  Shock       Date:  2013-08       Impact factor: 3.454

5.  Soluble CD14 is a nonspecific marker of monocyte activation.

Authors:  Carey L Shive; Wei Jiang; Donald D Anthony; Michael M Lederman
Journal:  AIDS       Date:  2015-06-19       Impact factor: 4.177

6.  Cd14 SNPs regulate the innate immune response.

Authors:  Hong-Hsing Liu; Yajing Hu; Ming Zheng; Megan M Suhoski; Edgar G Engleman; David L Dill; Matt Hudnall; Jianmei Wang; Rosanne Spolski; Warren J Leonard; Gary Peltz
Journal:  Mol Immunol       Date:  2012-03-23       Impact factor: 4.407

7.  Phosphodiesterase 4b expression plays a major role in alcohol-induced neuro-inflammation.

Authors:  Diana V Avila; Scott A Myers; JingWen Zhang; Giorgi Kharebava; Craig J McClain; Hee-Yong Kim; Scott R Whittemore; Leila Gobejishvili; Shirish Barve
Journal:  Neuropharmacology       Date:  2017-08-12       Impact factor: 5.250

8.  Soluble CD14 activates monocytic cells independently of lipopolysaccharide.

Authors:  R Landmann; S Link; S Sansano; Z Rajacic; W Zimmerli
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

9.  Frequencies of FoxP3+ naive T cells are related to both viral load and naive T cell proliferation responses in HIV disease.

Authors:  Benigno Rodriguez; Douglas A Bazdar; Nicholas Funderburg; Robert Asaad; Angel A Luciano; Gopal Yadavalli; Robert C Kalayjian; Michael M Lederman; Scott F Sieg
Journal:  J Leukoc Biol       Date:  2011-06-07       Impact factor: 4.962

10.  Expression, regulation and clinical significance of soluble and membrane CD14 receptors in pediatric inflammatory lung diseases.

Authors:  Veronica Marcos; Phillip Latzin; Andreas Hector; Sebastian Sonanini; Florian Hoffmann; Martin Lacher; Barbara Koller; Philip Bufler; Thomas Nicolai; Dominik Hartl; Matthias Griese
Journal:  Respir Res       Date:  2010-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.